1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Potential subtype-specific therapeutic approaches in small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Small cells – big issues : biological implications and preclinical advancements in small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
2024) In Cell Death and Differentiation(
- Contribution to journal › Article
-
Mark
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
(
- Contribution to journal › Article
- 2023
-
Mark
Laser ablation-inductively coupled plasma-mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
(
- Contribution to journal › Article
-
Mark
Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms
(
- Contribution to journal › Article
-
Mark
Unfolding the secrets of small cell lung cancer progression : Novel approaches and insights through rapid autopsies
(
- Contribution to journal › Debate/Note/Editorial